Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
148.41
+0.60 (0.41%)
At close: Dec 4, 2025, 4:00 PM EST
148.94
+0.90 (0.61%)
Pre-market: Dec 5, 2025, 5:44 AM EST
Axsome Therapeutics Market Cap
Axsome Therapeutics has a market cap or net worth of $7.48 billion as of December 5, 2025. Its market cap has increased by 66.99% in one year.
Market Cap
7.48B
Enterprise Value
7.36B
1-Year Change
66.99%
Ranking
Category
Stock Price
$148.41
Market Cap Chart
Since November 19, 2015, Axsome Therapeutics's market cap has increased from $154.90M to $7.48B, an increase of 4,730.05%. That is a compound annual growth rate of 47.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 7.46B | 82.01% |
| Dec 31, 2024 | 4.10B | 8.87% |
| Dec 29, 2023 | 3.77B | 12.44% |
| Dec 30, 2022 | 3.35B | 135.22% |
| Dec 31, 2021 | 1.42B | -53.19% |
| Dec 31, 2020 | 3.04B | -14.70% |
| Dec 31, 2019 | 3.57B | 4,141.14% |
| Dec 31, 2018 | 84.10M | -36.58% |
| Dec 29, 2017 | 132.60M | 2.55% |
| Dec 30, 2016 | 129.30M | -21.30% |
| Dec 31, 2015 | 164.30M | 6.07% |
| Nov 19, 2015 | 154.90M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |